Bipolar I Disorder and Manic Episodes

Core Idea

Bipolar I Disorder involves distinct manic episodes with abnormally elevated or irritable mood, decreased sleep need, racing thoughts, and risky behavior, paired with major depressive episodes. Manic episodes cause significant impairment and may include psychotic features. Treatment requires mood-stabilizing pharmacotherapy and psychosocial support.

Explainer

From your study of DSM-5 classification, you know that mood disorders are defined by episodes — bounded periods of abnormal mood — rather than trait-level personality characteristics. Bipolar I Disorder is anchored by one specific episode type: the full manic episode. A manic episode requires at least one week of abnormally elevated, expansive, or irritable mood, accompanied by at least three of a cluster of symptoms: inflated self-esteem or grandiosity, decreased need for sleep (not just insomnia — the person genuinely feels rested after three hours), pressured speech, flight of ideas (racing thoughts that jump rapidly between loosely connected topics), distractibility, increased goal-directed activity, and excessive involvement in risky behaviors. The episode must be severe enough to cause marked functional impairment or require hospitalization, or it must include psychotic features — either of which automatically qualifies it as Bipolar I.

The distinction between Bipolar I and Bipolar II is often misunderstood: Bipolar I requires at least one full manic episode; Bipolar II requires at least one hypomanic episode (a less severe, shorter-duration variant that does not cause marked impairment or include psychosis) and at least one major depressive episode. The presence of a full manic episode alone, even without a depressive episode, meets criteria for Bipolar I. Major depressive episodes are common in Bipolar I and cause significant burden, but they are not required by definition. This matters clinically because the treatment of bipolar depression differs importantly from unipolar depression — antidepressant monotherapy can trigger manic switching in bipolar patients.

Your prerequisite knowledge of the dopamine reward system provides a neurobiological framework for understanding mania. Dopamine is the primary neuromodulator of goal-directed motivation, reward anticipation, and energetic arousal. Mania can be conceptualized as a state of pathological reward system hyperactivation — dopaminergic circuits in the mesolimbic pathway become dysregulated, producing the cardinal features: inflated sense of goal importance, diminished fatigue, compressed sleep need, and reduced risk perception. The grandiosity and risky behavior are not simply "feeling good" — they reflect a distorted motivational state in which the subjective value of goals is catastrophically inflated and the perceived cost of actions is correspondingly reduced. This is why manic patients often engage in business ventures, sexual behavior, or spending sprees that they would recognize as catastrophically unwise outside of an episode.

Psychotic features in mania — when present — are typically mood-congruent: grandiose delusions (believing one has special powers or is on a divine mission) and, less commonly, auditory hallucinations. This contrasts with the mood-incongruent or bizarre psychosis of schizophrenia, though the distinction can be difficult to make in acute presentation, which is why a careful longitudinal history is essential. The episodic nature of bipolar disorder — periods of normal functioning between episodes — is diagnostically important and distinguishes it from the more chronic course of psychotic disorders. Mood stabilizers such as lithium, valproate, and atypical antipsychotics are the mainstay of treatment because they reduce episode frequency and severity across both poles, rather than simply targeting one mood state.